INTRODUCTION:B cells have many different roles in systemic lupus erythematosus (SLE), ranging from autoantigen recognition and processing to effector functions (for example, autoantibody and cytokine secretion). Recent studies have shown that intracellular nucleic acid-sensing receptors, Toll-like receptor (TLR) 7 and TLR9, play an important role in the pathogenesis of SLE. Dual engagement of rheumatoid factor-specific AM14 B cells through the B-cell receptor (BCR) and TLR7/9 results in marked proliferation of autoimmune B cells. Thus, strategies to preferentially block innate activation through TLRs in autoimmune B cells may be preferred over non-selective B-cell depletion.METHODS:We have developed a new generation of DNA-like compounds na...
Objectives. Toll-like receptor 9 (TLR9) is a pattern-associated receptor functioning in innate immun...
Activation of the innate immune system by toll-like receptors (TLR) provides an early response to pa...
The pathological DNA-specific B lymphocytes in lupus are logical targets for a selected therapeutic ...
INTRODUCTION. B cells have many different roles in systemic lupus erythematosus (SLE), ranging from ...
Systemic autoimmune disease is characterized by loss of immunologic tolerance to a restricted set of...
SummaryAntibodies (Abs) to RNA- and DNA-containing autoantigens are characteristic of systemic lupus...
One of the hallmarks of the autoimmune disease systemic lupus erythematosus (SLE) is the production ...
The generation of anti-DNA auto-antibodies is characteristic for the human autoimmune condition syst...
Activation of TLR7 and TLR9 by endogenous RNA- or DNA-containing ligands, respective-ly, is thought ...
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease associated with hormonal, environ...
Inhibitory oligodeoxynucleotides (INH-ODN) can exert an immunomodulatory effect to specifically bloc...
INTRODUCTION: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by th...
Thesis (Ph.D.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Autho...
SummarySystemic lupus erythematosus (SLE) is characterized by the production of autoantibodies that ...
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by B cell hyperactivity l...
Objectives. Toll-like receptor 9 (TLR9) is a pattern-associated receptor functioning in innate immun...
Activation of the innate immune system by toll-like receptors (TLR) provides an early response to pa...
The pathological DNA-specific B lymphocytes in lupus are logical targets for a selected therapeutic ...
INTRODUCTION. B cells have many different roles in systemic lupus erythematosus (SLE), ranging from ...
Systemic autoimmune disease is characterized by loss of immunologic tolerance to a restricted set of...
SummaryAntibodies (Abs) to RNA- and DNA-containing autoantigens are characteristic of systemic lupus...
One of the hallmarks of the autoimmune disease systemic lupus erythematosus (SLE) is the production ...
The generation of anti-DNA auto-antibodies is characteristic for the human autoimmune condition syst...
Activation of TLR7 and TLR9 by endogenous RNA- or DNA-containing ligands, respective-ly, is thought ...
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease associated with hormonal, environ...
Inhibitory oligodeoxynucleotides (INH-ODN) can exert an immunomodulatory effect to specifically bloc...
INTRODUCTION: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by th...
Thesis (Ph.D.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Autho...
SummarySystemic lupus erythematosus (SLE) is characterized by the production of autoantibodies that ...
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by B cell hyperactivity l...
Objectives. Toll-like receptor 9 (TLR9) is a pattern-associated receptor functioning in innate immun...
Activation of the innate immune system by toll-like receptors (TLR) provides an early response to pa...
The pathological DNA-specific B lymphocytes in lupus are logical targets for a selected therapeutic ...